insights_auto
Why is 524494 down 3,51%?
Dive Deeperchevron_right
524494:BOM
IPCA Laboratories Ltd
1 845,00 ₹
arrow_downward
-3,51%(-67,20) 1D
16 қаз., 15:30:00 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 524494...
Open
1 913,95 ₹
High
1 913,95 ₹
Low
1 812,60 ₹
Mkt. cap
468,21 млрд
Avg. vol.
27,90 мың
Volume
12,00 мың
Dividend
0,33%
Quarterly dividend
1,50 ₹
Ex-dividend date
2026 ж. 07 там.
P/E ratio
35,74
52-wk high
2 039,30 ₹
52-wk low
1 252,95 ₹
EPS
51,63 ₹
Shares outstanding
126,35 млн
No. of employees
17 мың
Open
1 913,95 ₹
High
1 913,95 ₹
Low
1 812,60 ₹
Mkt. cap
468,21 млрд
Avg. vol.
27,90 мың
Volume
12,00 мың
Dividend
0,33%
Quarterly dividend
1,50 ₹
Ex-dividend date
2026 ж. 07 там.
P/E ratio
35,74
52-wk high
2 039,30 ₹
52-wk low
1 252,95 ₹
EPS
51,63 ₹
Shares outstanding
126,35 млн
No. of employees
17 мың
News stories
From web sources and news partners
MarketBeat
·
6 минут бұрын
ProQR Therapeutics N.V. (NASDAQ:PRQR) Stock Has Consensus Price Target of $7.60 According to Analysts
Yahoo Finance
·
39 минут бұрын
Sandisk Is Dominating the S&P 500 in 2026. Can It Repeat in 2027?
MarketBeat
·
6 минут бұрын
The Simply Good Foods Company (NASDAQ:SMPL) Stock Now Rated "Hold" by Wall Street Brokerages
WSJ
·
1 күн бұрын
U.S. Stocks Fall as Credit Fears Haunt Tech Sector
Profile
Ipca Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. The company manufactures and markets more than 350 finished-dosage formulations and around 80 active pharmaceutical ingredients, covering therapeutic areas that include pain management, rheumatology, antimalarials, cardiovascular medicine, dermatology and anti-diabetics, and has an emerging biosimilars business. Its products are sold in over 100 countries, and it is one of India's larger API exporters, supplying more than 70 countries.
Ipca is one of the largest global suppliers of the antimalarials hydroxychloroquine and chloroquine, as well as of APIs such as atenolol, chlorthalidone, losartan and metoprolol. Since 2023, it has held a majority stake in Unichem Laboratories. The company is listed on the BSE and the National Stock Exchange of India, and reported consolidated revenue of ₹9,646 crore in the financial year ended 31 March 2026. Wikipedia
About IPCA Laboratories Ltd
CEO-
Employees17,2 мың
Founded1949 ж. 19 қаз.
Headquarters-
SectorPharmaceutical industry
Websiteipca.com